Male infertility is a significant global concern, responsible for 20-30% of total cases. Existing treatment options, such as surgery, hormonal therapy, and drug therapy, are often costly, uncertain in their effectiveness, and come with potential side effects. Meyer Vitabiotics, a subsidiary of Vitabiotics Ltd, the UK’s leading vitamin company, has conducted a study demonstrating the potential of antioxidant micronutrients and vitamins in improving male fertility.
The trial involved 300 Indian males with varying types and degrees of infertility, and tested the effectiveness of Oligocare Forte Plus, a supplement containing multi-vitamins, minerals, essential amino acids, ginseng, and lycopene. Results showed a 75.76% increase in sperm count among males with a baseline sperm count of less than 5 million/ml.
The Oligocare Forte Plus tablet, also known as Wellman Conception in the UK, combines essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health. Antioxidants frequently prescribed for treating male infertility include vitamins E and C, carnitine, N-acetyl cysteine, selenium, and zinc.
The promising results of the study highlight the potential of antioxidant micronutrient therapy as a more accessible, cost-effective, and clinically efficient alternative to traditional treatment options for male infertility. Meyer Vitabiotics’ groundbreaking research offers hope for millions of men worldwide who suffer from male factor infertility, providing valuable insights into the impact of antioxidant therapy on improving semen parameters and the DNA Fragmentation Index (DFI).